Corvus Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRVS and other ETFs, options, and stocks.

About CRVS

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. 

CEO
Richard A. Miller
CEORichard A. Miller
Employees
28
Employees28
Headquarters
Burlingame, California
HeadquartersBurlingame, California
Founded
2014
Founded2014
Employees
28
Employees28

CRVS Key Statistics

Market cap
73.07M
Market cap73.07M
Price-Earnings ratio
-2.71
Price-Earnings ratio-2.71
Dividend yield
—
Dividend yield—
Average volume
125.03K
Average volume125.03K
High today
$1.60
High today$1.60
Low today
$1.48
Low today$1.48
Open price
$1.60
Open price$1.60
Volume
90.47K
Volume90.47K
52 Week high
$4.19
52 Week high$4.19
52 Week low
$0.9777
52 Week low$0.9777
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.